Our cross-tissue study highlighting TIMP1 differential expression in the TME and its association with a gene signature indicative of peptide loading onto MHC-I molecules in tumor-draining LNs underscores a pivotal functional link for TIMP-1 in tumor immunogenicity. This evidence concerns the gene TIMP1 and neoplasm.